Luma Vision announced that it completed 15 AFib ablation procedures as part of a clinical study in collaboration with CardioFocus.

Makers of smartwatches and other wearables have spent years trying to measure blood sugar without pricking your skin. The ...

The trial’s primary efficacy endpoint is AF burden, which refers to the percentage of time a participant is in AF.

Acesion Pharma has begun enrolling patients into a phase 2 clinical trial of AP31969, its novel oral SK ion channel inhibitor being developed for rhythm control in atrial fibrillation.

AP31969 is a novel, first-in-class, oral SK ion channel inhibitor intended for rhythm control of atrial fibrillation and has recently completed Phase 1 in healthy volunteersPhase 2 trial will assess ...

On the eve of CES 2026 in Las Vegas, we look back at the best products we saw last January to see which ones delivered on ...

After approval in late 2024, Johnson & Johnson's Varipulse PFA system started 2025 on the wrong foot: Its early rollout had ...

On Monday, the U.S. Food and Drug Administration (FDA) approved Abbott Laboratories’ (NYSE: ABT) Volt PFA System to treat patients battling atrial fibrillation (AFib). AFib is the most common type of ...

CHICAGO (WLS) -- An alleged serial puncher has been ordered detained on Friday after officials say he attacked at least six women in separate incidents downtown. The state's attorney's office says ...

Why are we asking for donations? Why are we asking for donations? This site is free thanks to our community of supporters. Voluntary donations from readers like you keep our news accessible for ...

Active Gear Review is supported by its audience. If you purchase through links on our site, we may earn an affiliate commission. Screenless health trackers seem to be quietly taking over the wellness ...